Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (“HAE”) attacks in patients in Europe, the US, Israel, and South Korea.

Biotechnology

Pharming Group

Pharming Group's headquarters in Leiden, Netherlands

Inés Bernal

Mireille Sanders

Anurag Relan

Dolf Kuijper

Stephen Toor

Alexander Breidenbach

Kenneth Lynard

Ewen Munro

Shawn Hayes

Mark Moore

Wesley Blankenship

Daniel Franks

Brian Hartline

Kurinji Krishnamoorthy

Hendrik van der Boog

Gregory Fuest

Caitlin Wagner

Katia Nouzille

Mike Hilton

Björn Peters

John Whalen

Andrew Baumker

Wilbert van de Veire

Ashma Riaz

Bart de Kok Ra

Nigel van Kampen

Rosemary van Giezen

Virginia Briones

Maryana Reurings-Tsiganko

Steven Baert

Deborah Jorn

Paul Sekhri

Barbara Yanni

Leonard Kruimer

Mark Pykett

Jabine van der Meijs

Description

People (5)

Jobs (0)